Indeed, treatment with LPA capable of inducing IFNAR1 ubiquitination protected wild type but not Ifnar1SA animals from toxic hepatitis and fulminant generalized inflammation (Fig 7). The gene discussed is IFNAR1; the disease is hepatitis A virus infection.